PubMed:20484118 / 0-188 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":105},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":105},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":105},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.\nCardiac-type sarco(endo)plasmic reticulum Ca(2)-ATPase (SERCA2a) plays a major rol"}

{"project":"ICD10","denotations":[{"id":"T1","span":{"begin":90,"end":104},"obj":"http://purl.bioontology.org/ontology/ICD10/I42.9"},{"id":"T2","span":{"begin":90,"end":104},"obj":"http://purl.bioontology.org/ontology/ICD10/I42"}],"text":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.\nCardiac-type sarco(endo)plasmic reticulum Ca(2)-ATPase (SERCA2a) plays a major rol"}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T1","span":{"begin":125,"end":147},"obj":"FMAID:162308"},{"id":"_T2","span":{"begin":125,"end":147},"obj":"FMAID:63842"},{"id":"_T3","span":{"begin":138,"end":147},"obj":"FMAID:94520"},{"id":"_T4","span":{"begin":138,"end":147},"obj":"FMAID:7646"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.\nCardiac-type sarco(endo)plasmic reticulum Ca(2)-ATPase (SERCA2a) plays a major rol"}

{"project":"GO-BP","denotations":[{"id":"T1","span":{"begin":28,"end":43},"obj":"http://purl.obolibrary.org/obo/GO_0016310"},{"id":"T6","span":{"begin":148,"end":150},"obj":"http://purl.obolibrary.org/obo/GO_0033968"}],"text":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.\nCardiac-type sarco(endo)plasmic reticulum Ca(2)-ATPase (SERCA2a) plays a major rol"}

{"project":"Allie","denotations":[{"id":"SS1_20484118_1_0","span":{"begin":119,"end":160},"obj":"expanded"},{"id":"SS2_20484118_1_0","span":{"begin":162,"end":169},"obj":"abbr"}],"relations":[{"id":"AE1_20484118_1_0","pred":"abbreviatedTo","subj":"SS1_20484118_1_0","obj":"SS2_20484118_1_0"}],"text":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.\nCardiac-type sarco(endo)plasmic reticulum Ca(2)-ATPase (SERCA2a) plays a major rol"}

{"project":"DisGeNET5_gene_disease","denotations":[{"id":"20484118-0#14#27#gene5350","span":{"begin":14,"end":27},"obj":"gene5350"},{"id":"20484118-0#81#104#diseaseC0853897","span":{"begin":81,"end":104},"obj":"diseaseC0853897"}],"relations":[{"id":"14#27#gene535081#104#diseaseC0853897","pred":"associated_with","subj":"20484118-0#14#27#gene5350","obj":"20484118-0#81#104#diseaseC0853897"}],"text":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.\nCardiac-type sarco(endo)plasmic reticulum Ca(2)-ATPase (SERCA2a) plays a major rol"}

{"project":"Lectin","denotations":[{"id":"Lectin_T1","span":{"begin":148,"end":150},"obj":"https://acgg.asia/db/lfdb/LfDB0227"}],"text":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.\nCardiac-type sarco(endo)plasmic reticulum Ca(2)-ATPase (SERCA2a) plays a major rol"}

{"project":"HP-phenotype","denotations":[{"id":"T1","span":{"begin":90,"end":104},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0001638"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.\nCardiac-type sarco(endo)plasmic reticulum Ca(2)-ATPase (SERCA2a) plays a major rol"}

{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":90,"end":104},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0004994"}],"text":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.\nCardiac-type sarco(endo)plasmic reticulum Ca(2)-ATPase (SERCA2a) plays a major rol"}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T1","span":{"begin":90,"end":104},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0001638"}],"text":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.\nCardiac-type sarco(endo)plasmic reticulum Ca(2)-ATPase (SERCA2a) plays a major rol"}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T1","span":{"begin":90,"end":104},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0004994"}],"text":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.\nCardiac-type sarco(endo)plasmic reticulum Ca(2)-ATPase (SERCA2a) plays a major rol"}

{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T1","span":{"begin":138,"end":147},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0007361"}],"text":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.\nCardiac-type sarco(endo)plasmic reticulum Ca(2)-ATPase (SERCA2a) plays a major rol"}

{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":105},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":105},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":105},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.\nCardiac-type sarco(endo)plasmic reticulum Ca(2)-ATPase (SERCA2a) plays a major rol"}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T1","span":{"begin":0,"end":105},"obj":"Sentence"}],"text":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.\nCardiac-type sarco(endo)plasmic reticulum Ca(2)-ATPase (SERCA2a) plays a major rol"}

{"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":138,"end":147},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0007361"}],"text":"Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.\nCardiac-type sarco(endo)plasmic reticulum Ca(2)-ATPase (SERCA2a) plays a major rol"}